Cross-Protection by mAb 8C6 mAb 8C6 was selected to evaluate its protective effectiveness for H1N1 SIV because of its high HI and NT titers
Cross-Protection by mAb 8C6 mAb 8C6 was selected to evaluate its protective effectiveness for H1N1 SIV because of its high HI and NT titers. the homologous VPC 23019 strain, which…